238 related articles for article (PubMed ID: 35018582)
1. Cardiac manifestations in primary antiphospholipid syndrome and their association to antiphospholipid antibodies' types and titers-cross-sectional study of Serbian cohort.
Djokovic A; Stojanovich L; Stanisavljevic N; Djokic S; Filipovic B; Matic P; Milanovic M; Apostolovic S; Saponjski J
Clin Rheumatol; 2022 May; 41(5):1447-1455. PubMed ID: 35018582
[TBL] [Abstract][Full Text] [Related]
2. Relationship between cerebrovascular and valvular manifestations in a Serbian cohort of patients with antiphospholipid syndrome.
Djokovic A; Stojanovich L; Stanisavljevic N; Banicevic S; Smiljanic D; Milovanovic B
Clin Exp Rheumatol; 2018; 36(5):850-855. PubMed ID: 29846156
[TBL] [Abstract][Full Text] [Related]
3. Association between systemic non-criteria APS manifestations and antibody type and level: results from the Serbian national cohort study.
Stojanovich L; Kontic M; Djokovic A; Marisavljevic D; Ilijevski N; Stanisavljevic N; Mikovic Z; Petkovic M; Kovcin V
Clin Exp Rheumatol; 2013; 31(2):234-42. PubMed ID: 23306109
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Serbian Primary Antiphospholipid Syndrome Patients Confirmed a Strong Association Between Livedo Reticularis and Arterial Thrombosis: A National Cross-Sectional Cohort Study.
Djokovic A; Stojanovich L; Stanisavljevic N; Matic P; Colic D; Skrijelj D; Djokic S; Filipovic B
J Clin Rheumatol; 2022 Oct; 28(7):362-366. PubMed ID: 35697016
[TBL] [Abstract][Full Text] [Related]
5. Association between cardiac manifestations and antiphospholipid antibody type and level in a cohort of Serbian patients with primary and secondary antiphospholipid syndrome.
Djokovic A; Stojanovich L; Kontic M; Stanisavljevic N; Radovanovic S; Marisavljevic D
Isr Med Assoc J; 2014 Mar; 16(3):162-7. PubMed ID: 24761704
[TBL] [Abstract][Full Text] [Related]
6. Antiphospholipid-mediated thrombosis: interplay between type of antibodies and localisation of lung, and cardiovascular incidences in primary antiphospholipid syndrome.
Stojanovich L; Djokovic A; Kontic M
Clin Exp Rheumatol; 2015; 33(4):531-6. PubMed ID: 26088955
[TBL] [Abstract][Full Text] [Related]
7. The cutaneous manifestations are significantly related to cerebrovascular in a Serbian cohort of patients with Hughes syndrome.
Stojanovich L; Djokovic A; Stanisavljevic N; Zdravkovic M
Lupus; 2018 Apr; 27(5):858-863. PubMed ID: 29301476
[TBL] [Abstract][Full Text] [Related]
8. Association between non-thrombotic neurological and cardiac manifestations in patients with antiphospholipid syndrome.
Stojanovich L; Kontic M; Smiljanic D; Djokovic A; Stamenkovic B; Marisavljevic D
Clin Exp Rheumatol; 2013; 31(5):756-60. PubMed ID: 23899875
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary events in antiphospholipid syndrome: influence of antiphospholipid antibody type and levels.
Stojanovich L; Kontic M; Djokovic A; Ilijevski N; Stanisavljevic N; Marisavljevic D
Scand J Rheumatol; 2012 May; 41(3):223-6. PubMed ID: 22324785
[TBL] [Abstract][Full Text] [Related]
10. IgA Antiphospholipid Antibodies in Antiphospholipid Syndrome and Systemic Lupus Erythematosus.
Reshetnyak T; Cheldieva F; Cherkasova M; Lila A; Nasonov E
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012697
[TBL] [Abstract][Full Text] [Related]
11. Are the cutaneous manifestations in patients with primary antiphospholipid syndrome a marker for predicting lung manifestations?
Kontic M; Stojanovich L; Mijailović-Ivković M; Velinović M; Srnka J; Zdravkovic M
Clin Exp Rheumatol; 2018; 36(1):56-61. PubMed ID: 28770705
[TBL] [Abstract][Full Text] [Related]
12. Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study.
Gkrouzman E; Willis R; Andrade D; Tektonidou MG; Pengo V; Ruiz-Irastorza G; Belmont HM; Fortin PR; Gerosa M; Signorelli F; Atsumi T; Branch DW; Nalli C; Rodriguez-Almaraz E; Petri MA; Cervera R; Knight JS; Efthymiou M; Cohen H; Bertolaccini ML; Erkan D; Roubey R;
Lab Invest; 2023 Jun; 103(6):100147. PubMed ID: 37044248
[TBL] [Abstract][Full Text] [Related]
13. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
14. Primary antiphospholipid syndrome as a cause of impaired left ventricular diastolic function: experience from a Serbian cohort.
Djokovic A; Stojanovich L; Stanisavljevic N; Veljic I; Todic B; Radovanovic S; Zivic R; Matic P; Filipovic B; Saponjski J; Apostolovic S; Zdravkovic M; Milic S; Shoenfeld Y
Clin Exp Rheumatol; 2023 Jan; 41(1):103-109. PubMed ID: 35485420
[TBL] [Abstract][Full Text] [Related]
15. Ophthalmologic manifestations in primary antiphospholipid syndrome patients: A cross-sectional analysis of a primary antiphospholipid syndrome cohort (APS-Rio) and systematic review of the literature.
Franco AMM; Medina FMC; Balbi GGM; Levy RA; Signorelli F
Lupus; 2020 Oct; 29(12):1528-1543. PubMed ID: 32814509
[TBL] [Abstract][Full Text] [Related]
16. Influence of antiphospholipid antibody levels and type on thrombotic manifestations: results from the Serbian National Cohort Study.
Stojanovich L; Markovic O; Marisavljevic D; Elezovic I; Ilijevski N; Stanisavljevic N
Lupus; 2012 Mar; 21(3):338-45. PubMed ID: 21993381
[TBL] [Abstract][Full Text] [Related]
17. Influence of gender on the clinical and laboratory spectra of patients with primary antiphospholipid syndrome.
de Carvalho JF
Rheumatol Int; 2011 May; 31(5):647-50. PubMed ID: 20058014
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and diagnostic value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome in Chinese patients.
Li S; Bai Y; Meng J; Wang Q; Tian X; Li M; Zeng X; Zhao J; Hu C
Front Immunol; 2023; 14():1107510. PubMed ID: 37122726
[TBL] [Abstract][Full Text] [Related]
19. IgA anticardiolipin and IgA anti-β2 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome.
Mattia E; Ruffatti A; Tonello M; Meneghel L; Robecchi B; Pittoni M; Gallo N; Salvan E; Teghil V; Punzi L; Plebani M
Clin Chem Lab Med; 2014 Sep; 52(9):1329-33. PubMed ID: 24651022
[TBL] [Abstract][Full Text] [Related]
20. Do all antiphospholipid antibodies confer the same risk for major organ involvement in systemic lupus erythematosus patients?
Riancho-Zarrabeitia L; Martínez-Taboada VM; Rúa-Figueroa I; Alonso F; Galindo-Izquierdo M; Ovalles J; Olivé-Marqués A; Mena Vázquez N; Calvo-Alén J; Menor Almagro R; Tomero Muriel E; Uriarte Isacelaya E; Boteanu A; Andres M; Freire González M; Santos Soler G; Ruiz-Lucea ME; Ibáñez-Barceló M; Castellví I; Galisteo C; Quevedo Vila V; Raya E; Narváez J; Expósito L; Hernández Beriaín JA; Horcada L; Aurrecoechea E; Pego Reigosa JM
Clin Exp Rheumatol; 2021; 39(3):555-563. PubMed ID: 32828148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
